Advaxis Inc (NASDAQ:ADXS)

0.68
Delayed Data
As of 3:59pm ET
 -0.017 / -2.44%
Today’s Change
0.21
Today|||52-Week Range
2.95
-20.72%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$42.8M

Company Description

Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. It has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ.

Contact Information

Advaxis, Inc.
305 College Road East
Princeton New Jersey 08540
P:(609) 452-9813
Investor Relations:

Employees

Shareholders

Other institutional9.45%
Mutual fund holders2.14%
Individual stakeholders0.11%

Top Executives

There are no executives to display.